Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Atlas Venture Fund X, L.P. | 10% Owner | Sep 16 | Sale | 53.22 | 2,115 | 112,560 | 1,593,785 | Sep 18 04:59 PM | Atlas Venture Fund X, L.P. | 10% Owner | Sep 15 | Sale | 53.16 | 260,894 | 13,869,125 | 1,595,900 | Sep 18 04:59 PM | Atlas Venture Fund X, L.P. | 10% Owner | Sep 14 | Sale | 53.05 | 94,440 | 5,010,042 | 1,856,794 | Sep 18 04:59 PM | Bryce Joanne | Chief Financial Officer | Sep 11 | Option Exercise | 9.86 | 2,500 | 24,650 | 3,760 | Sep 13 04:15 PM | Bryce Joanne | Chief Financial Officer | Sep 01 | Option Exercise | 2.65 | 1,000 | 2,650 | 2,260 | Sep 05 04:16 PM | Bryce Joanne | Chief Financial Officer | Sep 01 | Sale | 52.99 | 1,000 | 52,990 | 1,260 | Sep 05 04:16 PM | Savage William Jacob | Chief Medical Officer | Aug 21 | Option Exercise | 2.65 | 3,000 | 7,950 | 3,000 | Aug 22 04:06 PM | Atlas Venture Fund X, L.P. | 10% Owner | Aug 15 | Sale | 52.40 | 111,069 | 5,820,016 | 1,951,234 | Aug 16 06:55 PM | Bitterman Kevin | Director | Aug 15 | Sale | 52.40 | 72,931 | 3,821,584 | 882,224 | Aug 17 04:13 PM | Atlas Venture Fund X, L.P. | 10% Owner | Aug 15 | Sale | 52.40 | 72,931 | 3,821,584 | 882,224 | Aug 16 06:55 PM | Savage William Jacob | Chief Medical Officer | Aug 15 | Sale | 52.95 | 7,672 | 406,235 | 0 | Aug 16 04:15 PM | Atlas Venture Fund X, L.P. | 10% Owner | Aug 14 | Sale | 52.59 | 175,000 | 9,203,600 | 2,062,303 | Aug 16 06:55 PM | Savage William Jacob | Chief Medical Officer | Aug 09 | Sale | 49.83 | 8,269 | 412,064 | 7,672 | Aug 11 04:15 PM | Bryce Joanne | Chief Financial Officer | Aug 01 | Option Exercise | 1.01 | 4,521 | 4,566 | 5,781 | Aug 03 04:18 PM | Bryce Joanne | Chief Financial Officer | Aug 01 | Sale | 49.91 | 4,521 | 225,633 | 1,260 | Aug 03 04:18 PM | MacDonald Brian Richard | Chief Innovation Officer | Jun 30 | Sale | 45.05 | 4,324 | 194,778 | 12,876 | Jun 30 06:29 PM | MacDonald Brian Richard | Chief Innovation Officer | Jun 29 | Sale | 45.79 | 5,100 | 233,509 | 17,200 | Jun 30 06:29 PM | Bryce Joanne | Chief Financial Officer | Jun 28 | Option Exercise | 1.01 | 7,880 | 7,959 | 11,332 | Jun 30 04:49 PM | Novo Holdings A/S | 10% Owner | Jun 28 | Sale | 46.10 | 1,250,000 | 57,625,000 | 1,090,772 | Jun 28 05:04 PM | Bryce Joanne | Chief Financial Officer | Jun 28 | Sale | 49.95 | 10,072 | 503,114 | 1,260 | Jun 30 04:49 PM | MacDonald Brian Richard | Chief Innovation Officer | Jun 28 | Sale | 49.96 | 5,100 | 254,795 | 22,300 | Jun 30 06:29 PM | Savage William Jacob | Chief Medical Officer | Jun 28 | Sale | 49.98 | 4,384 | 219,114 | 15,941 | Jun 30 04:12 PM | AI DMI LLC | 10% Owner | Feb 15 | Buy | 23.00 | 434,783 | 10,000,009 | 3,141,759 | Feb 17 04:42 PM | Ashiya Mona | Director | Feb 15 | Buy | 23.00 | 108,696 | 2,500,008 | 1,196,825 | Feb 17 04:48 PM | ORBIMED ADVISORS LLC | Director | Feb 15 | Buy | 23.00 | 108,696 | 2,500,008 | 1,196,825 | Feb 17 04:43 PM |
|